148 related articles for article (PubMed ID: 35217872)
1. Management of prostate cancer in older patients.
Narita S; Hatakeyama S; Sakamoto S; Kato T; Inokuchi J; Matsui Y; Kitamura H; Nishiyama H; Habuchi T
Jpn J Clin Oncol; 2022 May; 52(6):513-525. PubMed ID: 35217872
[TBL] [Abstract][Full Text] [Related]
2. [Prostate cancer in older men : Special features of the diagnostics and treatment].
Degener S; Schmalz O; Tosch M; Gödde D; von Rundstedt FC; Piroth MD
Z Gerontol Geriatr; 2023 Jul; 56(4):324-334. PubMed ID: 37306771
[TBL] [Abstract][Full Text] [Related]
3. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
Mottet N; Bellmunt J; Bolla M; Briers E; Cumberbatch MG; De Santis M; Fossati N; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; Matveev VB; Moldovan PC; van den Bergh RCN; Van den Broeck T; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Cornford P
Eur Urol; 2017 Apr; 71(4):618-629. PubMed ID: 27568654
[TBL] [Abstract][Full Text] [Related]
4. Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology.
Droz JP; Balducci L; Bolla M; Emberton M; Fitzpatrick JM; Joniau S; Kattan MW; Monfardini S; Moul JW; Naeim A; van Poppel H; Saad F; Sternberg CN
BJU Int; 2010 Aug; 106(4):462-9. PubMed ID: 20346033
[TBL] [Abstract][Full Text] [Related]
5. Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology.
Droz JP; Aapro M; Balducci L; Boyle H; Van den Broeck T; Cathcart P; Dickinson L; Efstathiou E; Emberton M; Fitzpatrick JM; Heidenreich A; Hughes S; Joniau S; Kattan M; Mottet N; Oudard S; Payne H; Saad F; Sugihara T
Lancet Oncol; 2014 Aug; 15(9):e404-14. PubMed ID: 25079103
[TBL] [Abstract][Full Text] [Related]
6. Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients.
Boyle HJ; Alibhai S; Decoster L; Efstathiou E; Fizazi K; Mottet N; Oudard S; Payne H; Prentice M; Puts M; Aapro M; Droz JP
Eur J Cancer; 2019 Jul; 116():116-136. PubMed ID: 31195356
[TBL] [Abstract][Full Text] [Related]
7. An evidence review of active surveillance in men with localized prostate cancer.
Ip S; Dahabreh IJ; Chung M; Yu WW; Balk EM; Iovin RC; Mathew P; Luongo T; Dvorak T; Lau J
Evid Rep Technol Assess (Full Rep); 2011 Dec; (204):1-341. PubMed ID: 23126653
[TBL] [Abstract][Full Text] [Related]
8. Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric Oncology.
Droz JP; Albrand G; Gillessen S; Hughes S; Mottet N; Oudard S; Payne H; Puts M; Zulian G; Balducci L; Aapro M
Eur Urol; 2017 Oct; 72(4):521-531. PubMed ID: 28089304
[TBL] [Abstract][Full Text] [Related]
9. Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions.
Loeb S; Zhou Q; Siebert U; Rochau U; Jahn B; Mühlberger N; Carter HB; Lepor H; Braithwaite RS
Eur Urol; 2017 Dec; 72(6):899-907. PubMed ID: 28844371
[TBL] [Abstract][Full Text] [Related]
10. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
11. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
Lancet Oncol; 2019 Feb; 20(2):267-281. PubMed ID: 30579763
[TBL] [Abstract][Full Text] [Related]
12. Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database.
Mahal AR; Butler S; Franco I; Muralidhar V; Larios D; Pike LRG; Zhao SG; Sanford NN; Dess RT; Feng FY; D'Amico AV; Spratt DE; Yu JB; Nguyen PL; Rebbeck TR; Mahal BA
Cancer; 2019 Oct; 125(19):3338-3346. PubMed ID: 31251398
[TBL] [Abstract][Full Text] [Related]
13. Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer.
Wilt TJ
Semin Urol Oncol; 2002 Feb; 20(1):10-7. PubMed ID: 11828353
[TBL] [Abstract][Full Text] [Related]
14. Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.
Lardas M; Liew M; van den Bergh RC; De Santis M; Bellmunt J; Van den Broeck T; Cornford P; Cumberbatch MG; Fossati N; Gross T; Henry AM; Bolla M; Briers E; Joniau S; Lam TB; Mason MD; Mottet N; van der Poel HG; Rouvière O; Schoots IG; Wiegel T; Willemse PM; Yuan CY; Bourke L
Eur Urol; 2017 Dec; 72(6):869-885. PubMed ID: 28757301
[TBL] [Abstract][Full Text] [Related]
15. Population-Based Assessment of Determining Treatments for Prostate Cancer.
Chamie K; Williams SB; Hu JC
JAMA Oncol; 2015 Apr; 1(1):60-7. PubMed ID: 26182305
[TBL] [Abstract][Full Text] [Related]
16. Radical prostatectomy versus deferred treatment for localised prostate cancer.
Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
[TBL] [Abstract][Full Text] [Related]
17. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
Johansson E; Bill-Axelson A; Holmberg L; Onelöv E; Johansson JE; Steineck G;
Eur Urol; 2009 Feb; 55(2):422-30. PubMed ID: 18783877
[TBL] [Abstract][Full Text] [Related]
18. A comment on the International Society of Geriatric Oncology guidelines: evidence-based advice for the clinical setting.
Fitzpatrick JM; Graefen M; Payne HA; Scotté F; Aapro MS
Oncologist; 2012; 17 Suppl 1(Suppl 1):31-5. PubMed ID: 23015683
[TBL] [Abstract][Full Text] [Related]
19. Management of older men with clinically localized prostate cancer: the significance of advanced age and comorbidity.
Hoffman KE
Semin Radiat Oncol; 2012 Oct; 22(4):284-94. PubMed ID: 22985811
[TBL] [Abstract][Full Text] [Related]
20. Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer.
Egger SJ; Calopedos RJ; O'Connell DL; Chambers SK; Woo HH; Smith DP
Eur Urol; 2018 Jun; 73(6):859-867. PubMed ID: 28851582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
